Therapeutic Group: Drugs of Nervous System, Anti Migraine Lasgrain 50: Each tablet contains Lasmiditan Hemisuccinate INN equivalent to Lasmiditan 50 mg. Lasgrain 100: Each tablet contains Lasmiditan Hemisuccinate INN equivalent to Lasmiditan 100 mg. Description Lasmiditan is a serotonin (5-HT) 1F receptor agonist. It binds with high affinity to the 5-HT1F receptor. It presumably exerts […]
Therapeutic Group: Others Presentation Larocentâ„¢ 25: Each capsule contains Larotrectinib sulfate INN equivalent to Larotrectinib 25 mg Larocentâ„¢ 100: Each capsule contains Larotrectinib sulfate INN equivalent to Larotrectinib 100 mg Description Larotrectinib is an inhibitor of the tropomyosin receptor kinases (TRK), TRKA, TRKB, and TRKC. In a broad panel of purified enzyme assays, larotrectinib inhibited […]
Therapeutic Group: Oncology Presentation Lapacent 250: Each tablet contains Lapatinib ditosylate monohydrate INN equivalent to Lapatinib 250 mg Description Lapatinib is a 4-anilinoquinazoline kinase inhibitor of the intracellular tyrosine kinase domains of both Epidermal Growth Factor Receptor (EGFR [ErbB1]) and of Human Epidermal Receptor Type 2 (HER2 [ErbB2]) receptors (estimated Kiapp values of 3nM and […]
Therapeutic Group: Drugs of Nervous System Presentation Lamogin 2: Each chewable/dispersible tablet contains Lamotrigine BP 2 mg. Lamogin 5: Each chewable/dispersible tablet contains Lamotrigine BP 5 mg. Lamogin 25: Each tablet contains Lamotrigine BP 25 mg. Lamogin 50: Each tablet contains Lamotrigine BP 50 mg. Description The precise mechanism(s) by which lamotrigine exerts its anticonvulsant […]
Therapeutic Group: Anti Viral Presentation Lamivir: Each film coated tablet contains Lamivudine INN 100 mg. Description Lamivudine is a synthetic nucleoside analogue with activity against Hepatitis B Virus (HBV) and Human Immunodeficiency Virus (HIV). Indications Lamivir is indicated for the treatment of chronic hepatitis B associated with evidence of hepatitis B viral replication and active […]
Therapeutic Group: Gastro Intestinal Disorders Presentation Inolac oral solution: Each 5 ml oral solution contains Lactulose USP 3.35 gm. Description Lactulose is a semi-synthetic disaccharide used in the treatment of constipation and hepatic encephalopathy. It consists of the monosaccharides fructose and galactose. In the colon, lactulose is broken down primarily to lactic acid, and also […]
Therapeutic Group: Paediatric Drops Presentation Ezymilk Paediatric Drops: Each ml drop contains Lactase USP 0.11g equivalent to 3333.33 units. Description Lactase is an enzyme that helps to prevent symptoms of lactose intolerance. It breaks down the lactose (milk sugar) to produce glucose and galactose via hydrolysis and making dairy food easier to digest. Indications Prevention […]
Therapeutic Group: Beta Blocker Presentation Labegest Injection: Each ml injectable solution contains Labetalol Hydrochloride BP 5 mg. Description Labetalol Hydrochloride is an adrenergic receptor blocking agents that have both selective alpha1-adrenergic and nonselective beta adrenergic receptor blocking actions. Both the alpha- and beta-blocking actions of orally administered Labetalol Hydrochloride contribute to a decrease in blood […]
Therapeutic Group: Beta Blocker Presentation Labegest 100: Each tablet contains Labetalol Hydrochloride BP 100 mg. Labegest 200: Each tablet contains Labetalol Hydrochloride BP 200 mg. Description Labetalol HCl is an adrenergic receptor blocking agents that have both selective alpha1-adrenergic and nonselective beta adrenergic receptor blocking actions. Both the alpha and beta-blocking actions of orally administered […]
Therapeutic Group: Others Presentation Hepaclin Granules for solution: Each sachet contains L-Ornithine L-Aspartate INN 3 gm. Hepaclin Injection (Infusion Concentrate): Each 10 ml injectable solution contains L-Ornithine L-Aspartate INN 5 gm. Description Hepaclin is a stable combination of two important endogenous Amino Acids, L-Ornithine and L-Aspartate. After administration, it quickly breaks down into L-Ornithine and […]